EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins

Yomnah Y Elsayed, Toni Kühl, Diana Imhof iD

Journal of Peptide Science · 2025-03 · 31 (3)

DOI: 10.1002/psc.70001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Peptide Science, online erschienen am 08.02.2025. Verfasst von Yomnah Y Elsayed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Peptides, Proteins. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptides and proteins have become increasingly important in the treatment of various diseases, including infections, metabolic disorders, and cancers. Over the past decades, the number of approved peptide‐ and protein‐based drugs has grown significantly, now accounting for about 25% of the global pharmaceutical market. This increase has been recorded since the introduction of the first therapeutic peptide, insulin, in 1921. Therapeutic peptides and proteins offer several advantages over small molecule drugs, including high specificity, potency, and safety; however, they also face challenges related to instability in liquid formulations. To address this issue, numerous formulation techniques have been developed to enhance their stability. In either state, physical and chemical characterization of the peptide or protein of interest is crucial for ensuring the identity, purity, and activity of these therapeutic agents. Regulatory bodies such as the FDA, ICH, and EMA have established guidelines for the analysis, stability testing, and quality control of peptides and biologics to ensure the safety and effectiveness of these drugs. In the present review, these guidelines and the consequences thereof are summarized and provided to support the notion of developing tailored bioanalytical workflows for each peptide or protein drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesProteinsHumansGuidelines as TopicUnited States

Stichwörter der Autor:innen

bioanalyticsexcipientsformulationguidelinespeptidesproteins

Substanzen

PeptidesProteins

Autor:innen und Institutionen

  • Pharmaceutical Biochemistry and Bioanalytics, Pharmaceutical Institute, University of Bonn, Bonn, Germany.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Diana Imhof

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Elsayed, Y. Y., Kühl, T., & Imhof, D. (2025). Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins. Journal of Peptide Science, 31(3). https://doi.org/10.1002/psc.70001

Vancouver

Elsayed YY, Kühl T, Imhof D. Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins. Journal of Peptide Science. 2025;31(3). doi:10.1002/psc.70001

BibTeX
@article{Elsayed2025,
  author = {Elsayed, Yomnah Y and Kühl, Toni and Imhof, Diana},
  title = {Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins},
  journal = {Journal of Peptide Science},
  year = {2025},
  volume = {31},
  number = {3},
  doi = {10.1002/psc.70001}
}
Kostenlos starten →